NVCR
NovocureยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NVCR Profile
Novocure Limited
A global oncology company that develops novel therapy for the treatment of solid tumor cancers including glioblastoma brain cancer
Healthcare Equipment and Supplies
02/11/2000
10/02/2015
NASDAQ Stock Exchange
1,488
12-31
Common stock
No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF
--
Novocure Limited is a public limited liability company incorporated under the laws of the Channel Islands of Jersey on February 11, 2000. The company is a commercial anti-tumor company that has developed a new proprietary therapy known as Oncology Therapeutics, or TTFields, to fight solid tumor cancers.
